img

Global Paediatric Gliomas Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Paediatric Gliomas Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Paediatric gliomas is a type of disorder that is characterized by the tumour of spinal cord or brain in children. It starts in glial cells that are present around the neurons, generating electrical impulses to transmit information, commonly known as glioma tumour. Moreover, the tumour causes complete damage in infratentorial brain functioning, including the brainstem and cerebellum. The most common symptoms in gliomas tumours include vomiting, headache, nausea, vision problems, and seizures.
Paediatric Gliomas Drugs report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Paediatric Gliomas Drugs market is projected to reach US$ 1523.3 million in 2029, increasing from US$ 1020 million in 2022, with the CAGR of 5.9% during the period of 2024 to 2029. Demand from Hospital and Specialist Clinic are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Paediatric Gliomas Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Mylan N.V
Teva Pharmaceutical Industries Ltd
Sanofi
Pfizer Inc
Novartis AG
Bayer AG
Merck & Co., Inc
AstraZeneca
Abbott
Bausch Health Companies Inc
Aurobindo Pharma
Lupin
Amneal Pharmaceuticals LLC
Sun Pharmaceutical Industries Ltd
Thermo Fisher Scientific Inc
Baxter
Hitachi, Ltd
Arbor Pharmaceuticals
Siemens Healthcare GmbH
Konninklije Philips N.V
Segment by Type
MTOR Inhibitors
MEK Blocker

Segment by Application


Hospital
Specialist Clinic
Other

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Paediatric Gliomas Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Paediatric Gliomas Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Paediatric Gliomas Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Paediatric Gliomas Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Paediatric Gliomas Drugs introduction, etc. Paediatric Gliomas Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Paediatric Gliomas Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Paediatric Gliomas Drugs Market Overview
1.1 Paediatric Gliomas Drugs Product Overview
1.2 Paediatric Gliomas Drugs Market Segment by Type
1.2.1 MTOR Inhibitors
1.2.2 MEK Blocker
1.3 Global Paediatric Gliomas Drugs Market Size by Type
1.3.1 Global Paediatric Gliomas Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Paediatric Gliomas Drugs Historic Market Size Review by Type (2018-2024)
1.3.3 Global Paediatric Gliomas Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Paediatric Gliomas Drugs Sales Breakdown by Type (2018-2024)
1.4.2 Europe Paediatric Gliomas Drugs Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Paediatric Gliomas Drugs Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Paediatric Gliomas Drugs Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Paediatric Gliomas Drugs Sales Breakdown by Type (2018-2024)
2 Global Paediatric Gliomas Drugs Market Competition by Company
2.1 Global Top Players by Paediatric Gliomas Drugs Sales (2018-2024)
2.2 Global Top Players by Paediatric Gliomas Drugs Revenue (2018-2024)
2.3 Global Top Players by Paediatric Gliomas Drugs Price (2018-2024)
2.4 Global Top Manufacturers Paediatric Gliomas Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Paediatric Gliomas Drugs Market Competitive Situation and Trends
2.5.1 Paediatric Gliomas Drugs Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Paediatric Gliomas Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Paediatric Gliomas Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Paediatric Gliomas Drugs Market
2.8 Key Manufacturers Paediatric Gliomas Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Paediatric Gliomas Drugs Status and Outlook by Region
3.1 Global Paediatric Gliomas Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Paediatric Gliomas Drugs Historic Market Size by Region
3.2.1 Global Paediatric Gliomas Drugs Sales in Volume by Region (2018-2024)
3.2.2 Global Paediatric Gliomas Drugs Sales in Value by Region (2018-2024)
3.2.3 Global Paediatric Gliomas Drugs Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Paediatric Gliomas Drugs Forecasted Market Size by Region
3.3.1 Global Paediatric Gliomas Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Paediatric Gliomas Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Paediatric Gliomas Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Paediatric Gliomas Drugs by Application
4.1 Paediatric Gliomas Drugs Market Segment by Application
4.1.1 Hospital
4.1.2 Specialist Clinic
4.1.3 Other
4.2 Global Paediatric Gliomas Drugs Market Size by Application
4.2.1 Global Paediatric Gliomas Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Paediatric Gliomas Drugs Historic Market Size Review by Application (2018-2024)
4.2.3 Global Paediatric Gliomas Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Paediatric Gliomas Drugs Sales Breakdown by Application (2018-2024)
4.3.2 Europe Paediatric Gliomas Drugs Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Paediatric Gliomas Drugs Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Paediatric Gliomas Drugs Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Paediatric Gliomas Drugs Sales Breakdown by Application (2018-2024)
5 North America Paediatric Gliomas Drugs by Country
5.1 North America Paediatric Gliomas Drugs Historic Market Size by Country
5.1.1 North America Paediatric Gliomas Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Paediatric Gliomas Drugs Sales in Volume by Country (2018-2024)
5.1.3 North America Paediatric Gliomas Drugs Sales in Value by Country (2018-2024)
5.2 North America Paediatric Gliomas Drugs Forecasted Market Size by Country
5.2.1 North America Paediatric Gliomas Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Paediatric Gliomas Drugs Sales in Value by Country (2024-2029)
6 Europe Paediatric Gliomas Drugs by Country
6.1 Europe Paediatric Gliomas Drugs Historic Market Size by Country
6.1.1 Europe Paediatric Gliomas Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Paediatric Gliomas Drugs Sales in Volume by Country (2018-2024)
6.1.3 Europe Paediatric Gliomas Drugs Sales in Value by Country (2018-2024)
6.2 Europe Paediatric Gliomas Drugs Forecasted Market Size by Country
6.2.1 Europe Paediatric Gliomas Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Paediatric Gliomas Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Paediatric Gliomas Drugs by Region
7.1 Asia-Pacific Paediatric Gliomas Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Paediatric Gliomas Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Paediatric Gliomas Drugs Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Paediatric Gliomas Drugs Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Paediatric Gliomas Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Paediatric Gliomas Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Paediatric Gliomas Drugs Sales in Value by Region (2024-2029)
8 Latin America Paediatric Gliomas Drugs by Country
8.1 Latin America Paediatric Gliomas Drugs Historic Market Size by Country
8.1.1 Latin America Paediatric Gliomas Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Paediatric Gliomas Drugs Sales in Volume by Country (2018-2024)
8.1.3 Latin America Paediatric Gliomas Drugs Sales in Value by Country (2018-2024)
8.2 Latin America Paediatric Gliomas Drugs Forecasted Market Size by Country
8.2.1 Latin America Paediatric Gliomas Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Paediatric Gliomas Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Paediatric Gliomas Drugs by Country
9.1 Middle East and Africa Paediatric Gliomas Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Paediatric Gliomas Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Paediatric Gliomas Drugs Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Paediatric Gliomas Drugs Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Paediatric Gliomas Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Paediatric Gliomas Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Paediatric Gliomas Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Mylan N.V
10.1.1 Mylan N.V Company Information
10.1.2 Mylan N.V Introduction and Business Overview
10.1.3 Mylan N.V Paediatric Gliomas Drugs Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Mylan N.V Paediatric Gliomas Drugs Products Offered
10.1.5 Mylan N.V Recent Development
10.2 Teva Pharmaceutical Industries Ltd
10.2.1 Teva Pharmaceutical Industries Ltd Company Information
10.2.2 Teva Pharmaceutical Industries Ltd Introduction and Business Overview
10.2.3 Teva Pharmaceutical Industries Ltd Paediatric Gliomas Drugs Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Teva Pharmaceutical Industries Ltd Paediatric Gliomas Drugs Products Offered
10.2.5 Teva Pharmaceutical Industries Ltd Recent Development
10.3 Sanofi
10.3.1 Sanofi Company Information
10.3.2 Sanofi Introduction and Business Overview
10.3.3 Sanofi Paediatric Gliomas Drugs Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Sanofi Paediatric Gliomas Drugs Products Offered
10.3.5 Sanofi Recent Development
10.4 Pfizer Inc
10.4.1 Pfizer Inc Company Information
10.4.2 Pfizer Inc Introduction and Business Overview
10.4.3 Pfizer Inc Paediatric Gliomas Drugs Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Pfizer Inc Paediatric Gliomas Drugs Products Offered
10.4.5 Pfizer Inc Recent Development
10.5 Novartis AG
10.5.1 Novartis AG Company Information
10.5.2 Novartis AG Introduction and Business Overview
10.5.3 Novartis AG Paediatric Gliomas Drugs Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Novartis AG Paediatric Gliomas Drugs Products Offered
10.5.5 Novartis AG Recent Development
10.6 Bayer AG
10.6.1 Bayer AG Company Information
10.6.2 Bayer AG Introduction and Business Overview
10.6.3 Bayer AG Paediatric Gliomas Drugs Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Bayer AG Paediatric Gliomas Drugs Products Offered
10.6.5 Bayer AG Recent Development
10.7 Merck & Co., Inc
10.7.1 Merck & Co., Inc Company Information
10.7.2 Merck & Co., Inc Introduction and Business Overview
10.7.3 Merck & Co., Inc Paediatric Gliomas Drugs Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Merck & Co., Inc Paediatric Gliomas Drugs Products Offered
10.7.5 Merck & Co., Inc Recent Development
10.8 AstraZeneca
10.8.1 AstraZeneca Company Information
10.8.2 AstraZeneca Introduction and Business Overview
10.8.3 AstraZeneca Paediatric Gliomas Drugs Sales, Revenue and Gross Margin (2018-2024)
10.8.4 AstraZeneca Paediatric Gliomas Drugs Products Offered
10.8.5 AstraZeneca Recent Development
10.9 Abbott
10.9.1 Abbott Company Information
10.9.2 Abbott Introduction and Business Overview
10.9.3 Abbott Paediatric Gliomas Drugs Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Abbott Paediatric Gliomas Drugs Products Offered
10.9.5 Abbott Recent Development
10.10 Bausch Health Companies Inc
10.10.1 Bausch Health Companies Inc Company Information
10.10.2 Bausch Health Companies Inc Introduction and Business Overview
10.10.3 Bausch Health Companies Inc Paediatric Gliomas Drugs Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Bausch Health Companies Inc Paediatric Gliomas Drugs Products Offered
10.10.5 Bausch Health Companies Inc Recent Development
10.11 Aurobindo Pharma
10.11.1 Aurobindo Pharma Company Information
10.11.2 Aurobindo Pharma Introduction and Business Overview
10.11.3 Aurobindo Pharma Paediatric Gliomas Drugs Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Aurobindo Pharma Paediatric Gliomas Drugs Products Offered
10.11.5 Aurobindo Pharma Recent Development
10.12 Lupin
10.12.1 Lupin Company Information
10.12.2 Lupin Introduction and Business Overview
10.12.3 Lupin Paediatric Gliomas Drugs Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Lupin Paediatric Gliomas Drugs Products Offered
10.12.5 Lupin Recent Development
10.13 Amneal Pharmaceuticals LLC
10.13.1 Amneal Pharmaceuticals LLC Company Information
10.13.2 Amneal Pharmaceuticals LLC Introduction and Business Overview
10.13.3 Amneal Pharmaceuticals LLC Paediatric Gliomas Drugs Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Amneal Pharmaceuticals LLC Paediatric Gliomas Drugs Products Offered
10.13.5 Amneal Pharmaceuticals LLC Recent Development
10.14 Sun Pharmaceutical Industries Ltd
10.14.1 Sun Pharmaceutical Industries Ltd Company Information
10.14.2 Sun Pharmaceutical Industries Ltd Introduction and Business Overview
10.14.3 Sun Pharmaceutical Industries Ltd Paediatric Gliomas Drugs Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Sun Pharmaceutical Industries Ltd Paediatric Gliomas Drugs Products Offered
10.14.5 Sun Pharmaceutical Industries Ltd Recent Development
10.15 Thermo Fisher Scientific Inc
10.15.1 Thermo Fisher Scientific Inc Company Information
10.15.2 Thermo Fisher Scientific Inc Introduction and Business Overview
10.15.3 Thermo Fisher Scientific Inc Paediatric Gliomas Drugs Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Thermo Fisher Scientific Inc Paediatric Gliomas Drugs Products Offered
10.15.5 Thermo Fisher Scientific Inc Recent Development
10.16 Baxter
10.16.1 Baxter Company Information
10.16.2 Baxter Introduction and Business Overview
10.16.3 Baxter Paediatric Gliomas Drugs Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Baxter Paediatric Gliomas Drugs Products Offered
10.16.5 Baxter Recent Development
10.17 Hitachi, Ltd
10.17.1 Hitachi, Ltd Company Information
10.17.2 Hitachi, Ltd Introduction and Business Overview
10.17.3 Hitachi, Ltd Paediatric Gliomas Drugs Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Hitachi, Ltd Paediatric Gliomas Drugs Products Offered
10.17.5 Hitachi, Ltd Recent Development
10.18 Arbor Pharmaceuticals
10.18.1 Arbor Pharmaceuticals Company Information
10.18.2 Arbor Pharmaceuticals Introduction and Business Overview
10.18.3 Arbor Pharmaceuticals Paediatric Gliomas Drugs Sales, Revenue and Gross Margin (2018-2024)
10.18.4 Arbor Pharmaceuticals Paediatric Gliomas Drugs Products Offered
10.18.5 Arbor Pharmaceuticals Recent Development
10.19 Siemens Healthcare GmbH
10.19.1 Siemens Healthcare GmbH Company Information
10.19.2 Siemens Healthcare GmbH Introduction and Business Overview
10.19.3 Siemens Healthcare GmbH Paediatric Gliomas Drugs Sales, Revenue and Gross Margin (2018-2024)
10.19.4 Siemens Healthcare GmbH Paediatric Gliomas Drugs Products Offered
10.19.5 Siemens Healthcare GmbH Recent Development
10.20 Konninklije Philips N.V
10.20.1 Konninklije Philips N.V Company Information
10.20.2 Konninklije Philips N.V Introduction and Business Overview
10.20.3 Konninklije Philips N.V Paediatric Gliomas Drugs Sales, Revenue and Gross Margin (2018-2024)
10.20.4 Konninklije Philips N.V Paediatric Gliomas Drugs Products Offered
10.20.5 Konninklije Philips N.V Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Paediatric Gliomas Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Paediatric Gliomas Drugs Industrial Chain Analysis
11.4 Paediatric Gliomas Drugs Market Dynamics
11.4.1 Paediatric Gliomas Drugs Industry Trends
11.4.2 Paediatric Gliomas Drugs Market Drivers
11.4.3 Paediatric Gliomas Drugs Market Challenges
11.4.4 Paediatric Gliomas Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Paediatric Gliomas Drugs Distributors
12.3 Paediatric Gliomas Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of MTOR Inhibitors
Table 2. Major Company of MEK Blocker
Table 3. Global Paediatric Gliomas Drugs Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Paediatric Gliomas Drugs Sales by Type (2018-2024) & (K Units)
Table 5. Global Paediatric Gliomas Drugs Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Paediatric Gliomas Drugs Sales by Type (2018-2024) & (US& Million)
Table 7. Global Paediatric Gliomas Drugs Market Share in Value by Type (2018-2024)
Table 8. Global Paediatric Gliomas Drugs Price by Type (2018-2024) & (US$/Unit)
Table 9. Global Paediatric Gliomas Drugs Sales by Type (2024-2029) & (K Units)
Table 10. Global Paediatric Gliomas Drugs Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Paediatric Gliomas Drugs Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Paediatric Gliomas Drugs Sales Market Share in Value by Type (2024-2029)
Table 13. Global Paediatric Gliomas Drugs Price by Type (2024-2029) & (US$/Unit)
Table 14. North America Paediatric Gliomas Drugs Sales by Type (2018-2024) & (K Units)
Table 15. North America Paediatric Gliomas Drugs Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Paediatric Gliomas Drugs Sales (K Units) by Type (2018-2024)
Table 17. Europe Paediatric Gliomas Drugs Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Paediatric Gliomas Drugs Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Paediatric Gliomas Drugs Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Paediatric Gliomas Drugs Sales (K Units) by Type (2018-2024)
Table 21. Latin America Paediatric Gliomas Drugs Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Paediatric Gliomas Drugs Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Paediatric Gliomas Drugs Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Paediatric Gliomas Drugs Sales by Company (2018-2024) & (K Units)
Table 25. Global Paediatric Gliomas Drugs Sales Share by Company (2018-2024)
Table 26. Global Paediatric Gliomas Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Paediatric Gliomas Drugs Revenue Share by Company (2018-2024)
Table 28. Global Market Paediatric Gliomas Drugs Price by Company (2018-2024) & (US$/Unit)
Table 29. Global Paediatric Gliomas Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Paediatric Gliomas Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Paediatric Gliomas Drugs as of 2022)
Table 32. Date of Key Manufacturers Enter into Paediatric Gliomas Drugs Market
Table 33. Key Manufacturers Paediatric Gliomas Drugs Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Paediatric Gliomas Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Paediatric Gliomas Drugs Sales by Region (2018-2024) & (K Units)
Table 37. Global Paediatric Gliomas Drugs Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Paediatric Gliomas Drugs Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Paediatric Gliomas Drugs Sales Market Share in Value by Region (2018-2024)
Table 40. Global Paediatric Gliomas Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 41. Global Paediatric Gliomas Drugs Sales by Region (2024-2029) & (K Units)
Table 42. Global Paediatric Gliomas Drugs Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Paediatric Gliomas Drugs Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Paediatric Gliomas Drugs Sales Market Share in Value by Region (2024-2029)
Table 45. Global Paediatric Gliomas Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 46. Global Paediatric Gliomas Drugs Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Paediatric Gliomas Drugs Sales by Application (2018-2024) & (K Units)
Table 48. Global Paediatric Gliomas Drugs Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Paediatric Gliomas Drugs Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Paediatric Gliomas Drugs Sales Market Share in Value by Application (2018-2024)
Table 51. Global Paediatric Gliomas Drugs Price by Application (2018-2024) & (US$/Unit)
Table 52. Global Paediatric Gliomas Drugs Sales by Application (2024-2029) & (K Units)
Table 53. Global Paediatric Gliomas Drugs Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Paediatric Gliomas Drugs Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Paediatric Gliomas Drugs Sales Market Share in Value by Application (2024-2029)
Table 56. Global Paediatric Gliomas Drugs Price by Application (2024-2029) & (US$/Unit)
Table 57. North America Paediatric Gliomas Drugs Sales by Application (2018-2024) (K Units)
Table 58. North America Paediatric Gliomas Drugs Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Paediatric Gliomas Drugs Sales by Application (2018-2024) (K Units)
Table 60. Europe Paediatric Gliomas Drugs Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Paediatric Gliomas Drugs Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Paediatric Gliomas Drugs Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Paediatric Gliomas Drugs Sales by Application (2018-2024) (K Units)
Table 64. Latin America Paediatric Gliomas Drugs Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Paediatric Gliomas Drugs Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Paediatric Gliomas Drugs Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Paediatric Gliomas Drugs Sales by Country (2018-2024) & (K Units)
Table 68. North America Paediatric Gliomas Drugs Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Paediatric Gliomas Drugs Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Paediatric Gliomas Drugs Sales Market Share in Value by Country (2018-2024)
Table 71. North America Paediatric Gliomas Drugs Sales by Country (2024-2029) & (K Units)
Table 72. North America Paediatric Gliomas Drugs Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Paediatric Gliomas Drugs Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Paediatric Gliomas Drugs Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Paediatric Gliomas Drugs Sales by Country (2018-2024) & (K Units)
Table 76. Europe Paediatric Gliomas Drugs Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Paediatric Gliomas Drugs Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Paediatric Gliomas Drugs Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Paediatric Gliomas Drugs Sales by Country (2024-2029) & (K Units)
Table 80. Europe Paediatric Gliomas Drugs Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Paediatric Gliomas Drugs Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Paediatric Gliomas Drugs Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Paediatric Gliomas Drugs Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Paediatric Gliomas Drugs Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Paediatric Gliomas Drugs Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Paediatric Gliomas Drugs Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Paediatric Gliomas Drugs Sales by Region (2024-2029) & (K Units)
Table 88. Asia-Pacific Paediatric Gliomas Drugs Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Paediatric Gliomas Drugs Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Paediatric Gliomas Drugs Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Paediatric Gliomas Drugs Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Paediatric Gliomas Drugs Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Paediatric Gliomas Drugs Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Paediatric Gliomas Drugs Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Paediatric Gliomas Drugs Sales by Country (2024-2029) & (K Units)
Table 96. Latin America Paediatric Gliomas Drugs Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Paediatric Gliomas Drugs Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Paediatric Gliomas Drugs Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Paediatric Gliomas Drugs Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Paediatric Gliomas Drugs Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Paediatric Gliomas Drugs Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Paediatric Gliomas Drugs Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Paediatric Gliomas Drugs Sales by Country (2024-2029) & (K Units)
Table 104. Middle East and Africa Paediatric Gliomas Drugs Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Paediatric Gliomas Drugs Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Paediatric Gliomas Drugs Sales Market Share in Value by Country (2024-2029)
Table 107. Mylan N.V Company Information
Table 108. Mylan N.V Introduction and Business Overview
Table 109. Mylan N.V Paediatric Gliomas Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Mylan N.V Paediatric Gliomas Drugs Product
Table 111. Mylan N.V Recent Development
Table 112. Teva Pharmaceutical Industries Ltd Company Information
Table 113. Teva Pharmaceutical Industries Ltd Introduction and Business Overview
Table 114. Teva Pharmaceutical Industries Ltd Paediatric Gliomas Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Teva Pharmaceutical Industries Ltd Paediatric Gliomas Drugs Product
Table 116. Teva Pharmaceutical Industries Ltd Recent Development
Table 117. Sanofi Company Information
Table 118. Sanofi Introduction and Business Overview
Table 119. Sanofi Paediatric Gliomas Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Sanofi Paediatric Gliomas Drugs Product
Table 121. Sanofi Recent Development
Table 122. Pfizer Inc Company Information
Table 123. Pfizer Inc Introduction and Business Overview
Table 124. Pfizer Inc Paediatric Gliomas Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Pfizer Inc Paediatric Gliomas Drugs Product
Table 126. Pfizer Inc Recent Development
Table 127. Novartis AG Company Information
Table 128. Novartis AG Introduction and Business Overview
Table 129. Novartis AG Paediatric Gliomas Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Novartis AG Paediatric Gliomas Drugs Product
Table 131. Novartis AG Recent Development
Table 132. Bayer AG Company Information
Table 133. Bayer AG Introduction and Business Overview
Table 134. Bayer AG Paediatric Gliomas Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Bayer AG Paediatric Gliomas Drugs Product
Table 136. Bayer AG Recent Development
Table 137. Merck & Co., Inc Company Information
Table 138. Merck & Co., Inc Introduction and Business Overview
Table 139. Merck & Co., Inc Paediatric Gliomas Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Merck & Co., Inc Paediatric Gliomas Drugs Product
Table 141. Merck & Co., Inc Recent Development
Table 142. AstraZeneca Company Information
Table 143. AstraZeneca Introduction and Business Overview
Table 144. AstraZeneca Paediatric Gliomas Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. AstraZeneca Paediatric Gliomas Drugs Product
Table 146. AstraZeneca Recent Development
Table 147. Abbott Company Information
Table 148. Abbott Introduction and Business Overview
Table 149. Abbott Paediatric Gliomas Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Abbott Paediatric Gliomas Drugs Product
Table 151. Abbott Recent Development
Table 152. Bausch Health Companies Inc Company Information
Table 153. Bausch Health Companies Inc Introduction and Business Overview
Table 154. Bausch Health Companies Inc Paediatric Gliomas Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Bausch Health Companies Inc Paediatric Gliomas Drugs Product
Table 156. Bausch Health Companies Inc Recent Development
Table 157. Aurobindo Pharma Company Information
Table 158. Aurobindo Pharma Introduction and Business Overview
Table 159. Aurobindo Pharma Paediatric Gliomas Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Aurobindo Pharma Paediatric Gliomas Drugs Product
Table 161. Aurobindo Pharma Recent Development
Table 162. Lupin Company Information
Table 163. Lupin Introduction and Business Overview
Table 164. Lupin Paediatric Gliomas Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Lupin Paediatric Gliomas Drugs Product
Table 166. Lupin Recent Development
Table 167. Amneal Pharmaceuticals LLC Company Information
Table 168. Amneal Pharmaceuticals LLC Introduction and Business Overview
Table 169. Amneal Pharmaceuticals LLC Paediatric Gliomas Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. Amneal Pharmaceuticals LLC Paediatric Gliomas Drugs Product
Table 171. Amneal Pharmaceuticals LLC Recent Development
Table 172. Sun Pharmaceutical Industries Ltd Company Information
Table 173. Sun Pharmaceutical Industries Ltd Introduction and Business Overview
Table 174. Sun Pharmaceutical Industries Ltd Paediatric Gliomas Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 175. Sun Pharmaceutical Industries Ltd Paediatric Gliomas Drugs Product
Table 176. Sun Pharmaceutical Industries Ltd Recent Development
Table 177. Thermo Fisher Scientific Inc Company Information
Table 178. Thermo Fisher Scientific Inc Introduction and Business Overview
Table 179. Thermo Fisher Scientific Inc Paediatric Gliomas Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 180. Thermo Fisher Scientific Inc Paediatric Gliomas Drugs Product
Table 181. Thermo Fisher Scientific Inc Recent Development
Table 182. Baxter Company Information
Table 183. Baxter Introduction and Business Overview
Table 184. Baxter Paediatric Gliomas Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 185. Baxter Paediatric Gliomas Drugs Product
Table 186. Baxter Recent Development
Table 187. Hitachi, Ltd Company Information
Table 188. Hitachi, Ltd Introduction and Business Overview
Table 189. Hitachi, Ltd Paediatric Gliomas Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 190. Hitachi, Ltd Paediatric Gliomas Drugs Product
Table 191. Hitachi, Ltd Recent Development
Table 192. Arbor Pharmaceuticals Company Information
Table 193. Arbor Pharmaceuticals Introduction and Business Overview
Table 194. Arbor Pharmaceuticals Paediatric Gliomas Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 195. Arbor Pharmaceuticals Paediatric Gliomas Drugs Product
Table 196. Arbor Pharmaceuticals Recent Development
Table 197. Siemens Healthcare GmbH Company Information
Table 198. Siemens Healthcare GmbH Introduction and Business Overview
Table 199. Siemens Healthcare GmbH Paediatric Gliomas Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 200. Siemens Healthcare GmbH Paediatric Gliomas Drugs Product
Table 201. Siemens Healthcare GmbH Recent Development
Table 202. Konninklije Philips N.V Company Information
Table 203. Konninklije Philips N.V Introduction and Business Overview
Table 204. Konninklije Philips N.V Paediatric Gliomas Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 205. Konninklije Philips N.V Paediatric Gliomas Drugs Product
Table 206. Konninklije Philips N.V Recent Development
Table 207. Key Raw Materials Lists
Table 208. Raw Materials Key Suppliers Lists
Table 209. Paediatric Gliomas Drugs Market Trends
Table 210. Paediatric Gliomas Drugs Market Drivers
Table 211. Paediatric Gliomas Drugs Market Challenges
Table 212. Paediatric Gliomas Drugs Market Restraints
Table 213. Paediatric Gliomas Drugs Distributors List
Table 214. Paediatric Gliomas Drugs Downstream Customers
Table 215. Research Programs/Design for This Report
Table 216. Key Data Information from Secondary Sources
Table 217. Key Data Information from Primary Sources
List of Figures
Figure 1. Paediatric Gliomas Drugs Product Picture
Figure 2. Global Paediatric Gliomas Drugs Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Paediatric Gliomas Drugs Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Paediatric Gliomas Drugs Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of MTOR Inhibitors
Figure 6. Global MTOR Inhibitors Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of MEK Blocker
Figure 8. Global MEK Blocker Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Global Paediatric Gliomas Drugs Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Paediatric Gliomas Drugs Sales Market Share by Type in 2022 & 2029
Figure 11. North America Paediatric Gliomas Drugs Sales Market Share in Volume by Type in 2022
Figure 12. North America Paediatric Gliomas Drugs Sales Market Share in Value by Type in 2022
Figure 13. Europe Paediatric Gliomas Drugs Sales Market Share in Volume by Type in 2022
Figure 14. Europe Paediatric Gliomas Drugs Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Paediatric Gliomas Drugs Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Paediatric Gliomas Drugs Sales Market Share in Value by Type in 2022
Figure 17. Latin America Paediatric Gliomas Drugs Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Paediatric Gliomas Drugs Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Paediatric Gliomas Drugs Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Paediatric Gliomas Drugs Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Paediatric Gliomas Drugs Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Paediatric Gliomas Drugs Revenue in 2022
Figure 23. Paediatric Gliomas Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Hospital
Figure 25. Global Hospital Sales YoY Growth (2018-2029) & (K Units)
Figure 26. Product Picture of Specialist Clinic
Figure 27. Global Specialist Clinic Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Other
Figure 29. Global Other Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Global Paediatric Gliomas Drugs Sales by Application (2018-2029) & (US$ Million)
Figure 31. Global Paediatric Gliomas Drugs Sales Market Share by Application in 2022 & 2029
Figure 32. North America Paediatric Gliomas Drugs Sales Market Share in Volume by Application in 2022
Figure 33. North America Paediatric Gliomas Drugs Sales Market Share in Value by Application in 2022
Figure 34. Europe Paediatric Gliomas Drugs Sales Market Share in Volume by Application in 2022
Figure 35. Europe Paediatric Gliomas Drugs Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Paediatric Gliomas Drugs Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Paediatric Gliomas Drugs Sales Market Share in Value by Application in 2022
Figure 38. Latin America Paediatric Gliomas Drugs Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Paediatric Gliomas Drugs Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Paediatric Gliomas Drugs Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Paediatric Gliomas Drugs Manufacturing Cost Structure
Figure 43. Paediatric Gliomas Drugs Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed